LON:GDR - Genedrive Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 24.50 0.00 (0.00 %) (As of 10/16/2018 04:00 PM ET)Previous CloseGBX 24.50Today's RangeGBX 21 - GBX 2152-Week RangeGBX 25 - GBX 44.50Volume1,149 shsAverage Volume9,606 shsMarket Capitalization£7.11 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionAnalyst RatingsChartEarnings HistoryInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics. The Preclinical Research Services division provides pre-clinical testing services in the areas of oncology, oncology supportive care, inflammatory bowel disease, leukaemia, gastrointestinal disease, inflammation, skin care and wound healing, and rheumatoid arthritis. The Pharmacogenomic Services division offers molecular measures of biological processes. The Diagnostics division is involved in commercializing the Genedrive point of need molecular testing platform. It serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is based in Manchester, the United Kingdom. Receive GDR News and Ratings via Email Sign-up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Diagnostics & Research Sub-IndustryN/A SectorMedical SymbolLON:GDR CUSIPN/A Webwww.genedriveplc.com Phone+44-161-9890245 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-128.59% Return on Equity-141.44% Return on Assets-53.48% Miscellaneous Employees79 Outstanding Shares18,690,000Market Cap£7.11 million Genedrive (LON:GDR) Frequently Asked Questions What is Genedrive's stock symbol? Genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR." How were Genedrive's earnings last quarter? Genedrive PLC (LON:GDR) released its quarterly earnings data on Tuesday, March, 20th. The company reported ($9.00) earnings per share (EPS) for the quarter. The business had revenue of $2.63 million for the quarter. Genedrive had a negative net margin of 128.59% and a negative return on equity of 141.44%. View Genedrive's Earnings History. What price target have analysts set for GDR? 1 Wall Street analysts have issued 12-month target prices for Genedrive's stock. Their forecasts range from GBX 152 to GBX 152. On average, they anticipate Genedrive's stock price to reach GBX 152 in the next year. This suggests a possible upside of 520.4% from the stock's current price. View Analyst Price Targets for Genedrive. What is the consensus analysts' recommendation for Genedrive? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genedrive in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genedrive. Who are some of Genedrive's key competitors? Some companies that are related to Genedrive include Co-Diagnostics (CODX), SQI Diagnostics (SQD), Parallax Health Sciences (PRLX), Cambridge Cognition (COG), LED Medical Diagnostics (LMD), 3D Signatures (DXD), GeneNews (GEN), Deepmatter Group (DMTR), Eternity Healthcare (ETAH), Imaging Dynamics (IDL), Med Biogene (MBI), Medical Imaging (MEDD), BioNano Genomics (BNGOU), Carl Data Solutions (CRL) and NationalResearchCorp . (NRC). Who are Genedrive's key executives? Genedrive's management team includes the folowing people: Mr. David Budd, Chief Exec. Officer and Director (Age 50)Mr. Matthew J. Fowler, CFO, Company Sec. & Director (Age 43) How do I buy shares of Genedrive? Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Genedrive's stock price today? One share of GDR stock can currently be purchased for approximately GBX 24.50. How big of a company is Genedrive? Genedrive has a market capitalization of £7.11 million. Genedrive employs 79 workers across the globe. What is Genedrive's official website? The official website for Genedrive is http://www.genedriveplc.com/. How can I contact Genedrive? Genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The company can be reached via phone at +44-161-9890245. MarketBeat Community Rating for Genedrive (LON GDR)Community Ranking: 3.0 out of 5 ( )Outperform Votes: 122 (Vote Outperform)Underperform Votes: 84 (Vote Underperform)Total Votes: 206MarketBeat's community ratings are surveys of what our community members think about Genedrive and other stocks. Vote "Outperform" if you believe GDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 10/16/2018 by MarketBeat.com StaffFeatured Article: What is Compound Annual Growth Rate (CAGR)?